Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial

1981, Timolol induced reductionin mortality and reinfarction in patients surviving acute myocardial infarction, N Engl J Med, 304, 801, 10.1056/NEJM198104023041401 1982, A randomised trial of propranolol in patients with acute myocardial infarction, I: mortality results, JAMA, 247, 1707, 10.1001/jama.1982.03320370021023 Yusuf, 1985, Beta blockade during and after myocardial infarction: an overview of the randomized trials, Prog Cardiovasc Dis, 27, 335, 10.1016/S0033-0620(85)80003-7 Packer, 1996, The effect of carvedilol on morbidity and mortality in patients with chronic heart failure, N Engl J Med, 334, 1349, 10.1056/NEJM199605233342101 1999, The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial, Lancet, 353, 9, 10.1016/S0140-6736(98)11181-9 1999, Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF), Lancet, 353, 2001, 10.1016/S0140-6736(99)04440-2 1997, Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease, Lancet, 349, 375, 10.1016/S0140-6736(97)80008-6 Spargias, 1999, β Blocker treatment and other prognostic variables in patients with clinical evidence of heart failure after acute myocardial infarction: evidence from the AIRE study, Heart, 81, 25, 10.1136/hrt.81.1.25 Freemantle, 1999, Beta-blockade after myocardial infarction: systematic review a d meta regression analysis, BMJ, 318, 1730, 10.1136/bmj.318.7200.1730 Vantrimpont, 1997, Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the Survival and For personal use. Only reproduce with permission from The Lancet Publishing Group. Ventricular Enlargement (SAVE) study, J Am Coll Cardiol, 29, 229, 10.1016/S0735-1097(96)00489-5 Pfeffer, 1992, Effect of captopril on mortality and morbididty in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial, N Engl J Med, 327, 669, 10.1056/NEJM199209033271001 1993, Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure, Lancet, 342, 821 Kober, 1995, A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction, N Engl J Med, 333, 1670, 10.1056/NEJM199512213332503 Krumholz, 1998, National use and effectiveness of beta blockers for the treatment of elderly patients after acute myocardial infarction, JAMA, 280, 623, 10.1001/jama.280.7.623 Gottlieb, 1998, Effect of beta blockade on mortality among high risk and low risk patients after myocardial infarction, N Engl J Med, 339, 489, 10.1056/NEJM199808203390801 Dargie, 2000, Design and methodology of the CAPRICORN trial: a randomized double blind placebo controlled study of the impact of carvedilol on morbidity and mortality in patients with left ventricular dysfunctionafter myocardial infarction, Eur J Heart Failure, 2, 325, 10.1016/S1388-9842(00)00098-2 Flather, 2000, Long-term ACE-inhibitor therapy in patients with heartfailure or left-ventricular dysfunction: a systematic overview of data from individual patients, Lancet, 355, 1575, 10.1016/S0140-6736(00)02212-1